🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Xiaoli Mi

Memorial Sloan Kettering Cancer Center

ORCID: 0000-0002-0348-1001

Also affiliated with Kettering University

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “E7820, an anti-cancer sulfonamide, degrades RBM39 in patients with splicing factor mutant myeloid malignancies: a phase II clinical trial”.

E7820, an anti-cancer sulfonamide, degrades RBM39 in patients with splicing factor mutant myeloid malignancies: a phase II clinical trial

Leukemia(2023)10.1038/s41375-023-02050-4
N/A
0.982DataRank · unranked
52 citations

Maximilian Stahl, Justin Taylor, Xiaoli Mi, Namrata S. Chandhok, Justin M. Watts +11 more

Safety and activity of selinexor in patients with myelodysplastic syndromes or oligoblastic acute myeloid leukaemia refractory to hypomethylating agents: a single-centre, single-arm, phase 2 trial

The Lancet Haematology(2020)10.1016/s2352-3026(20)30209-x
N/A
0.843DataRank · unranked
21 citations

Xiaoli Mi, Alexander Penson, Stella Paffenholz, Kelsey Alvarez, Allison Sigler +10 more

Systematic evaluation of AML-associated antigens identifies anti-U5 SNRNP200 therapeutic antibodies for the treatment of acute myeloid leukemia

Nature Cancer(2023)10.1038/s43018-023-00656-2
N/A
0DataRank · unranked
23 citations

Jahan Rahman, Caroline Erickson, Eric Wang, Mara Monetti, Zhuoning Li +21 more

Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127

Science(2024)10.1126/science.adi5798
N/A
0DataRank · unranked
152 citations

Jessie Bourcier, Mark Noviski, Hao Lu, Meghan C. Thompson, Alexandra Chirino +48 more

Augmenting CAR T-cell Functions with LIGHT

Cancer Immunology Research(2024)10.1158/2326-6066.cir-24-0246
N/A
0DataRank · unranked
4 citations

Kento Tanaka, Xiaoli Mi, Vinagolu K. Rajasekhar, Jonathan F. Khan, Sarah Yoo +15 more

Phase Ib study of PRT543, an oral protein arginine methyltransferase 5 (PRMT5) inhibitor, in patients with advanced splicing factor-mutant myeloid malignancies

Leukemia(2025)10.1038/s41375-025-02515-8
N/A
0DataRank · unranked
13 citations

Xiaoli Mi, Bin Lü, Andrew Kuykendall, David A. Sallman, Manish R. Patel +16 more